Questions and answers
How were the standards developed?
The standards development process began with a comprehensive review of current hospital-based neurodiagnostics standards by an expert advisory panel to the DAP. This panel included neurologists, physiatrists, and technologists. Once draft standards were written, program staff distributed them to all neurologists registered with the DAP for feedback, and conducted pilot assessments at two community neurodiagnostics facilities. Knowledge gained from these pilot assessments was used to revise the draft standards, which were then forwarded to the DAP Committee for approval.
Where are these standards applicable?
These standards apply to all community neurodiagnostics facilities. The DAP defines “community neurodiagnostics” as neurodiagnostic testing performed outside of the hospital in a physician office setting. Neurodiagnostic testing includes electromyography (EMG) and nerve conduction studies (NCS).
What does this mean for community neurodiagnostic practices?
The standards are now in effect for all community neurodiagnostic facilities and will be used for the assessment of facilities in September 2017. Program staff will be contacting community neurodiagnostic facilities over the coming months to inform them of their assessment date and to offer support and information about the accreditation process and these standards.
A complete copy of the standards can be downloaded from the DAP website here.
Mr. Nav Rakhra
Accreditation Research and Development Officer
Diagnostic Accreditation Program